Valeo Financial Advisors, LLC Intellia Therapeutics, Inc. Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$60.88 - $161.91 $248,512 - $660,916	-4,082 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$46.59 - $83.68 $232,950 - $418,400	-5,000 Reduced 55.05%	4,082 $328,000
Q2 2020 Jul 20, 2020	BUY	$11.14 - $22.87 $92,584 - $190,072	8,311 Added 1077.95%	9,082 $191,000
Q1 2019 Apr 12, 2019	BUY	$12.79 - $17.62 $7,789 - $10,730	609 Added 375.93%	771 $13,000
Q3 2018 Nov 01, 2018	BUY	$25.78 - $32.6 $2,113 - $2,673	82 Added 102.5%	162 $3,000
Q3 2017 Nov 15, 2017	BUY	$15.16 - $25.75 $1,212 - $2,060	80	80 $2,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.06B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.